Pharmacy staff resillience training (FOI)Pharmacy staff resillience training (FOI)
Produced by the Freedom of Information officeAuthored by Government of Jersey and published on
27 September 2024.Prepared internally, no external costs.
Request
A
As mentioned in the recent independent review of the Jersey General Hospital Pharmacy Department; how much did the 'resilience training' for pharmacy staff cost?
B
Please confirm how many man-hours were spent undertaking this training?
Response
A
The value of individual engagements or contracts is commercially sensitive, and as such, Health and Community Services (HCS) considers that disclosure of such detail would likely prejudice the commercial interests of the department, or others. Therefore, Article 33 of the Freedom of Information (Jersey) Law 2011 has been applied.
B
Training was delivered in sessions, with 12 hours available to each person. A total of 576 hours allocated across the Pharmacy team. In addition to the training sessions, all members of the team have permanent access to online resources provided.
Article applied
Article 33 - Commercial interests
Information is qualified exempt information if –
(a) it constitutes a trade secret; or
(b) its disclosure would, or would be likely to, prejudice the commercial interests of a person (including the scheduled public authority holding the information).
Public Interest Test
Article 33 is a qualified exemption and as such, HCS has conducted a prejudice test as required by law.
When responding to requests of this nature, HCS has to balance the public interest with the impact that disclosing this information would, or would be likely to, have upon the organisation and / or third parties. Whilst it may be in the public interest to understand the costs of contracting services, protecting the commercial interests of HCS is an essential component in controlling public finances, which in itself is in the public interest.
It has been concluded that disclosing details of the contractual service arrangements is likely to prejudice the commercial interests of HCS and / or the provider. When considering the application of this exemption, HCS has determined that whilst it is in the public interest to disclose information, this is outweighed by the necessity to limit any impact on the commercial interests of HCS and third parties in future contract negotiations, and as such, Article 33 has been applied.